Texas FreshAir 2014 Conference - Houston
Texas FreshAIR Inaugural Roundtable
Lilly Day - Dallas
Lilly Day - Houston
BioNews Texas article
BioNews Texas article
The University of Texas System FreshAIR initiative is an effort to create successful partnerships* between UT System health institutions and the life sciences industry.
The University of Texas System hosts some of the world's premier health research institutions:
The University of Texas M. D. Anderson Cancer Center (Houston)
The University of Texas Southwestern Medical Center (Dallas)
The University of Texas Health Science Center at Houston
The University of Texas Medical Branch at Galveston
The University of Texas Health Science Center at San Antonio
The University of Texas Health Science Center at Tyler
A key objective for the UT System is to increase the public-private partnerships as outlined in Chancellor Francisco Cigarroa's 2011 A Framework for Advancing Excellence.
Federal funding for basic, clinical and translational research is increasingly uncertain.
Science-based partnerships* between academia and industry offer advantages to both entities. Together they can address the challenge of developing innovative drugs for their mutual benefit and the well-being of society.
Texas has a unique population that includes a large Hispanic population in South Texas and mirrors the future population of the United States.
Collaborations between academia and industry ensure that Texas remains competitive as a strong player in science and biotechnology.
Access to pre-publication research inventory of each institution with potential commercial impact in early discovery research, clinical research and drug discovery with periodic up-dates.
Access to the UT clinical site networks for the conduct of clinical trials through the Texas CTSA Consortium.
Opportunity for dialog between industry and UT System researchers through regular roundtable events focused by therapeutic area.
Opportunity to interface with UT System trainees, graduate students and post-doctoral fellows.
Access to simplified processes such as IRB reciprocity between institutions and a standard licensing agreement.
*The term "partnerships" is used to describe a broad range of agreements between an academic institution and a life sciences company to share materials, resources and/or intellectual property, including but not restricted to acquisition and licensing.
(Adopted from Deloitte R&D Article Series - Re-igniting the R&D engine in a constrained environment, 2010.)